Life ScienceCompany
Where is Proteomedix headquartered?
Proteomedix is headquartered in Schlieren, Switzerland.
What sector is Proteomedix in?
Proteomedix is a life science company.
Proteomedix is headquartered in Schlieren, Switzerland.
Proteomedix is a life science company.
Wagistrasse 23,
Schlieren,
8952
Switzerland,
www.farfetchgroupcareers.com
Proteomedix is a healthcare company whose mission is to transform prostate cancer diagnosis. The company has identified novel biomarker signatures with utility in prostate cancer diagnosis, prognosis, and therapy management. Its product Proclarix is a blood-based prostate cancer test panel and risk score currently available in Europe and expected to be available in the U.S. Proteomedix is based in Schlieren, Switzerland.
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.